GMP Supplier Oxaliplatin for Injection 50mg, 100mg

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Injection
• Model NO.: Oxaliplatin for Injection
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Powder
• Type: Organic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Dosage Form: Sterile Powder for Injection
• Registration Support: Professional Team
• Standard: USP, Cp
• Ctd: Available
• Copp: Available
• Transport Package: Carton
• Specification: 50mg, 100mg
• Trademark: Customerized
• Origin: China
• HS Code: 3006930000
• Production Capacity: 150 Million Vials/Year

Product Description

Product Description

Assay	Comply with In-house standard.
Application	Pharma grade
Packing	10KG/Drum,15KG/Drum,25KG/Drum or Customerized
DMF files	Available
Registration Support	Available for all the markets

Detailed Photos


Certifications


Company Profile

Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd. founded in March 2011, is the wholly-owned subsidiary company of Shandong Luoxin Pharmaceutical Group Stock Co. Ltd., which has been successively put into operation since 2013. It is located in Feixian Economic Development Zone(West Side of Yanbin Road, Economic Development Zone, Feixian, Linyi, Shandong, P.R. China) It mainly constructs several production lines with cephalosporin API (sterile and non-sterile), chemicals API (sterile and non-sterile), anti-tumor API(non-sterile) according to GMP standards and European Certification standards.
To ensure product quality and GMP implementation requirements, our company have established and improved the Quality Management System The system is equipped with the quality director, which is in charge of quality management of the company and serves as quality authorizer at the same time. The quality authorizer has jurisdiction over QA dept.and QC dept.,and is responsible for all the quality-related work in the company. Up to now, our company has successfully passed 16 certifications at home and abroad.
 

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate that is engaged in pharmaceutical research and development, manufacture, sales, and healthcare service. There are six manufacturing sites covering formulations, APIs and Intermediates, Chinese medicine and its extracts and Medical apparatus and instruments products. Benefiting from the layout structure of the whole industry chain, Luoxin Pharmaceutical has a strong development momentum and successfully listed on the A-share market in 2019.